Testosterone Supplementation in Older Men: A Rational Idea Whose Time Has Not Yet Come
2001; Wiley; Volume: 22; Issue: 5 Linguagem: Inglês
10.1002/j.1939-4640.2001.tb02570.x
ISSN2047-2927
AutoresShalender Bhasin, J. Galen Buckwalter,
Tópico(s)Pharmacological Effects and Assays
ResumoJournal of AndrologyVolume 22, Issue 5 p. 718-731 Free Access Testosterone Supplementation in Older Men: A Rational Idea Whose Time Has Not Yet Come SHALENDER BHASIN, Corresponding Author SHALENDER BHASIN Division of Endocrinology, Metabolism, and Molecular Medicine, Department of Internal Medicine, Charles R. Drew University of Medicine and Science, University of California at Los Angeles, Los Angeles, California Division of Endocrinology, Metabolism, and Molecular Medicine, Department of Internal Medicine, Charles R. Drew University of Medicine and Science, University of California at Los Angeles, Los Angeles, CA 90059 (e-mail: [email protected]).Search for more papers by this authorJ. GALEN BUCKWALTER, J. GALEN BUCKWALTER Department of Research and Evaluation, Southern California Kaiser Permanente Medical Group, Pasadena, California.Search for more papers by this author SHALENDER BHASIN, Corresponding Author SHALENDER BHASIN Division of Endocrinology, Metabolism, and Molecular Medicine, Department of Internal Medicine, Charles R. Drew University of Medicine and Science, University of California at Los Angeles, Los Angeles, California Division of Endocrinology, Metabolism, and Molecular Medicine, Department of Internal Medicine, Charles R. Drew University of Medicine and Science, University of California at Los Angeles, Los Angeles, CA 90059 (e-mail: [email protected]).Search for more papers by this authorJ. GALEN BUCKWALTER, J. GALEN BUCKWALTER Department of Research and Evaluation, Southern California Kaiser Permanente Medical Group, Pasadena, California.Search for more papers by this author First published: 02 January 2013 https://doi.org/10.1002/j.1939-4640.2001.tb02570.xCitations: 12AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References Alexander G. Androgens and behavior in men. In: C. Wang, ed. Male Reproductive Function. Vol 5. Boston, Mass: Kluwer Academic Pub-lishers; 1999: 191–205. Alexandersen P., Haarbo J., Christiansen C. The relationship of natural androgens to coronary heart disease in males: a review. Atherosclerosis. 1996; 125: 1–13. American Medical Association. White paper on elderly health. Report of the Council on Scientific Affairs [published erratum appears in Arch Intern Med. 1991; 151: 265]. Arch Intern Med. 1990; 150: 2459–2472. Anderson FH, Francis RM, Peaston RT, Wastell HJ. Androgen supplementation in eugonadal men with osteoporosis: effects of 6 months treatment on markers of bone formation and resorption. J Bone Miner Res. 1997; 12: 472–478. Andropause Consensus Statement. Endocrine Society, 2000. Arlt W., Callies F., Van Vlijmen JC, et al. Dehydroepiandrosterone replacement in women with adrenal insufficiency. N Engl J Med. 1999; 341: 1013–1020. Arver S., Dobs AS, Meikle AW, Allen RP, Sanders SW, Mazer NA. Improvement of sexual function in testosterone deficient men treated for 1 year with a permeation enhanced testosterone transdermal system. J Urol. 1996; 155: 1604–1608. Bagatell CJ, Heiman J.R., Rivier JE, Bremner WJ. Effects of endogenous testosterone and estradiol on sexual behavior in normal young men [published erratum appears in J Clin Endocrinol Metab. 1994; 78: 1520]. J Clin Endocrinol Metab. 1994; 78: 711–716. Bakhshi V., Elliott M., Gentili A., Godschalk M., Mulligan T. Testosterone improves rehabilitation outcomes in ill older men. J Am Geriatr Soc. 2000; 48: 550–553. Bancroft J., Wu FC. Changes in erectile responsiveness during androgen replacement therapy. Arch Sex Behav. 1983; 12: 59–66. Barrett-Connor E., Goodman-Gruen D., Patay B. Endogenous sex hormones and cognitive function in older men. J Clin Endocrinol Metab. 1999a; 84: 3681–3685. Barrett-Connor E., Khaw KT. Endogenous sex hormones and cardiovascular disease in men. A prospective population-based study. Circulation. 1988; 78: 539–545. Barrett-Conner E., Von Muhlen DG, Kritz-Silverstein D. Bioavailable testosterone and depressed mood in older men: the Rancho Bernardo study. J Clin Endocrinol Metab. 1999b; 84: 573–577. Bassey EJ, Fiatarone MA, O'Neill EF, Kelly M., Evans WJ. Leg extensor power and functional performance in very old men and women. Clin Sci. 1992; 82: 321–327. Baumgartner RN, Koehler KM, Gallagher D., Romero L., Heymsfield SB, Ross RR, Garry PJ, Lindeman RD. Epidemiology of sarcopenia among the elderly in New Mexico [published erratum appears in Am J Epidemiol. 1999; 149: 1161]. Am J Epidemiol. 1998; 147: 755–763. Behre HM, Bohmeyer J., Nieschlag E. Prostate volume in testosterone-treated and untreated hypogonadal men in comparison to age-matched normal controls. Clin Endocrinol (Oxf). 1994; 40: 341–349. Behre HM, Kliesch S., Leifke E., Link TM, Nieschlag E. Long-term effect of testosterone therapy on bone mineral density in hypogonadal men. J Clin Endocrinol Metab. 1997; 82: 2386–2390. Bhasin S., Fielder T., Peacock N., Sod-Moriah UA, Swerdloff RS. Dissociating antifertility effects of GnRH-antagonist from its adverse effects on mating behavior in male rats. Am J Physiol. 1988; 254: E84–E91. Bhasin S., Storer TW, Berman N., et al. The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men [see comments]. N Engl J Med. 1996; 335: 1–7. Bhasin S., Storer TW, Berman N., et al. Testosterone replacement increases fat-free mass and muscle size in hypogonadal men. J Clin Endocrinol Metab. 1997a; 82: 407–413. Bhasin S., Storer TW, Javanbakht M., et al. Testosterone replacement and resistance exercise in HIV-infected men with weight loss and low testosterone levels [see comments]. JAMA. 2000; 283: 763–770. Bhasin S., Tenover JS. Age-associated sarcopenia—issues in the use of testosterone as an anabolic agent in older men. J Clin Endocrinol Metab. 1997b; 82: 1659–1660. Bonjour J-P, Theintz G., Buchs B., Slosman D., Rizzoli R. Critical years and stages of puberty for spinal and femoral bone mass and accumulation during adolescence. J Clin Endocrinol Metab. 1991; 73: 555–563. Borkan GA, Hults DE, Gerzof SG, Robbins AH, Silbert CK. Age changes in body composition revealed by computed tomography. J Gerontol. 1983; 38: 673–677. Borkan GA, Norris AH. Fat redistribution and the changing body dimensions of the adult male. Hum Biol. 1977; 49: 495–513. Bremner WJ, Prinz PN. A loss of circadian rhythmicity in blood testosterone levels with aging in normal men. J Clin Endocrinol Metab. 1983; 56: 1278–1281. Brodsky IG, Balagopal P., Nair KS. Effects of testosterone replacement on muscle mass and muscle protein synthesis in hypogonadal men—a clinical research center study. J Clin Endocrinol Metab. 1996; 75: 1092–1098. Buena F., Swerdloff RS, Steiner BS, Lutchmansingh P., Peterson MA, Pandian MR, Galmarini M., Bhasin S. Sexual function does not change when serum testosterone levels are pharmacologically varied within the normal male range. Fertil Steril. 1993; 59: 1118–1123. Buvat J., Lemaire A. Endocrine screening in 1,022 men with erectile dysfunction: clinical significance and cost-effective strategy [see comments]. J Urol. 1997; 158: 1764–1767. Carani C., Granata AR, Bancroft J., Marrama P. The effects of testosterone replacement on nocturnal penile tumescence and rigidity and erectile response to visual erotic stimuli in hypogonadal men. Psychoneuroendocrinology. 1995; 20: 743–753. Carani C., Zini D., Baldini A., Casa L. Della, Ghizzani A., Marrama P. Effects of androgen treatment in impotent men with normal and low levels of free testosterone. Arch Sex Behav. 1990; 19: 223–234. Carter HB, Pearson JD, Metter EJ, Chan DW, Andres R., Fozard JL, Rosner W., Walsh PC. Longitudinal evaluation of serum androgen levels in men with and without prostate cancer. Prostate. 1995a; 27: 25–31. Carter HB, Pearson JD, Waclawiw Z., Metter EJ, Chan DW, Guess HA, Walsh PC. Prostate-specific antigen variability in men without prostate cancer: effect of sampling interval on prostate-specific antigen velocity. Urology. 1995b; 45: 591–596. Center J.R., Nguyen TV, Sambrook PN, Eisman JA. Hormonal and biochemical parameters in the determination of osteoporosis in elderly men. J Clin Endocrinol Metab. 1999; 84: 3626–3635. Christiansen K. Sex hormone-related variations of cognitive performance in !Kung San hunter-gatherers of Namibia. Neuropsychobiology. 1993; 27: 97–107. Citron JT, Ettinger B., Rubinoff H., Ettinger VM, Minkoff J., Hom F., Kan P., Alloo R. Prevalence of hypothalamic-pituitary imaging abnormalities in impotent men with secondary hypogonadism. J Urol. 1996; 155: 529–533. Cistulli PA, Grunstein RR, Sullivan CE. Effect of testosterone administration on upper airway collapsibility during sleep. Am J Respir Crit Care Med. 1994; 149: 530–532. Cohn SH, Vartsky D., Yasumura S., Sawitsky A., Zanzi I., Vaswani A., Ellis KJ. Compartmental body composition based on total-body nitrogen, potassium, and calcium. Am J Physiol. 1980; 239: E524–E530. Cohn SH, Vaswani AN, Yasumura S., Yuen K., Ellis KJ. Assessment of cellular mass and lean body mass by noninvasive nuclear techniques. J Lab Clin Med. 1985; 105: 305–311. Colvard DS, Eriksen EF, Keeting PE, Wilson EM, Lubahn DB, French FS, Riggs BL, Spelsberg TC. Identification of androgen receptors in normal human osteoblast-like cells. Proc Natl Acad Sci USA. 1989; 86: 854–857. Cooper CS, Perry PJ, Sparks AE, MacIndoe JH, Yates WR, Williams RD. Effect of exogenous testosterone on prostate volume, serum and semen prostate specific antigen levels in healthy young men. J Urol. 1998; 159: 441–443. Crist DM, Peake GT, Stackpole PJ. Lipemic and lipoproteinemic effects of natural and synthetic androgens in humans. Clin Exp Pharmacol Physiol. 1986; 13: 513–518. Daniell HW. Osteoporosis after orchiectomy for prostate cancer. J Urol. 1997; 157: 439–444. Davidson JM, Camargo CA, Smith ER. Effects of androgen on sexual behavior in hypogonadal men. J Clin Endocrinol Metab. 1979; 48: 955–958. Davidson JM, Chen JJ, Crapo L., Gray GD, Greenleaf WJ, Catania JA. Hormonal changes and sexual function in aging men. J Clin Endocrinol Metab. 1983; 57: 71–77. Defay R., Papoz L., Barny S., Bonnot-Lours S., Caces E., Simon D. Hormonal status and NIDDM in the European and Melanesian populations of New Caledonia: a case-control study. The CALedonia DIAbetes Mellitus (CALDIA) Study Group. Int J Obes Relat Metab Disord. 1998; 22: 927–934. De Pergola G., De Mitrio V., Sciaraffia M., et al. Lower androgenicity is associated with higher plasma levels of prothrombotic factors irrespective of age, obesity, body fat distribution, and related metabolic parameters in men. Metabolism. 1997; 46: 1287–1293. Dexter DD, Dovre EJ. Obstructive sleep apnea due to endogenous testosterone production in a woman. Mayo Clin Proc. 1998; 73: 246–248. Dobs AS, Meikle AW, Arver S., Sanders SW, Caramelli KE, Mazer NA. Pharmacokinetics, efficacy, and safety of a permeation-enhanced testosterone transdermal system in comparison with bi-weekly injections of testosterone enanthate for the treatment of hypogonadal men. J Clin Endocrinol Metab. 1999; 84: 3469–3478. Dorner G., Hinz G. Androgen dependent brain differentiation and life span. Endokrinologie. 1975; 65: 378–380. Dutta C., Hadley EC. The significance of sarcopenia in old age. J Gerontol A Biol Sci Med Sci. 1995; 50 (special): 1–4. Emery MJ, Hlastala MP, Matsumoto AM. Depression of hypercapnic ventilatory drive by testosterone in the sleeping infant primate. J Appl Physiol. 1994; 76: 1786–1793. Endre T., Mattiasson I., Berglund G., Hulthen UL. Low testosterone and insulin resistance in hypertension-prone men. J Hum Hypertens. 1996; 10: 755–761. Eriksson S., Eriksson A., Stege R., Carlstrom K. Bone mineral density in patients with prostate cancer treated with orchiectomy and with estrogens. Calcif Tissue Int. 1995; 57: 97–99. Evans WJ. Effects of exercise on body composition and functional capacity of the elderly. J Gerontol. 1995; 50A: 147–150. Falahati-Nini A., Riggs BL, Atkinson EJ, O'Fallon WM, Eastell R., Khosla S. Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men. J Clin Invest. 2000; 106: 1553–1560. Fielder TJ, Peacock NR, McGivern RF, Swerdloff RS, Bhasin S. Testosterone dose-dependency of sexual and nonsexual behaviors in the gonadotropin-releasing hormone antagonist-treated male rat. J Androl. 1989; 10: 167–173. Fink G., Sumner BEH, McQueen JK, Wilson H., Rosie R. Sex steroid control of mood, mental state and memory. Clin Exp Pharmacol Physiol. 1998; 25: 764–775. Finkelstein JS, Klibanski A., Neer RM, Greenspan SL, Rosenthal DI, Crowley WF Jr. Osteoporosis in men with idiopathic hypogonadotropic hypogonadism. Ann Intern Med. 1987; 106: 354–361. Flegg JL Lakatta ed. Role of muscle loss in the age-associated reductions in VO2max. J Appl Physiol. 1988; 65: 1147–1151. Forbes GB, Reina JC. Adult lean body mass declines with age: some longitudinal observations. Metabolism. 1970; 19: 653–663. Fried W., Marver D., Lange RD, Gurney CW. Studies on the erythropoietic stimulating factor in the plasma of mice after receiving testosterone. J Lab Clin Med. 1966; 68: 947–951. Frontera WR, Hughes VR, Lutz KJ, Evans WJ. A cross-sectional study of muscle strength and mass in 45- to 75-yr-old men and women. J Appl Physiol. 1991; 71: 644–650. Goldray D., Weisman Y., Jaccard N., Merdler C., Chen J., Matzkin H. Decreased bone mineral density in elderly men treated with gonadotropin-releasing hormone agonist decapeptyl (D-Trp6-GnRH). J Clin Endocrinol Metab. 1993; 76: 288–290. Gormley GJ, Stoner E., Bruskewitz RC, et al. The effect of finasteride in men with benign prostatic hyperplasia. The Finasteride Study Group. N Engl J Med. 1992; 327: 1185–1191. Gouchie C., Kimura D. The relationship between testosterone levels and cognitive ability patterns. Psychoneuroendocrinology. 1991; 16: 323–334. Goulding A., Gold E. Flutamide-mediated androgen blockade evokes osteopenia in the female rat. J Bone Miner Res. 1993; 8: 763–769. Gray A., Feldman HA, McKinlay JB, Longcope C. Age, disease, and changing sex hormone levels in middle-aged men: results of the Massachusetts Male Aging Study. J Clin Endocrinol Metab. 1991; 73: 1016–1025. Greendale GA, Edelstein S., Barrett-Connor E. Endogenous sex steroids and bone mineral density in older women and men: the Rancho Bernardo Study. J Bone Miner Res. 1997; 12: 1833–1843. Grinspoon S., Corcoran C., Stanley T., Baaj A., Basgoz N., Klibanski A. Effects of hypogonadism and testosterone administration on depression indices in HIV-infected men. J Clin Endocrinol Metab. 2000; 85: 60–65. Grunstein RR. Metabolic aspects of sleep apnea. Sleep. 1996; 19 (suppl): S218–S220. Haffner SM, Laakso M., Miettinen H., Mykkanen L., Karhapaa P., Rainwater DL. Low levels of sex hormone-binding globulin and testosterone are associated with smaller, denser low density lipoprotein in normoglycemic men [see comments]. J Clin Endocrinol Metab. 1996a; 81: 3697–3701. Haffner SM, Shaten J., Stern MP, Smith GD, Kuller L. Low levels of sex hormone-binding globulin and testosterone predict the development of non-insulin-dependent diabetes mellitus in men. MRFIT Research Group. Multiple Risk Factor Intervention Trial. Am J Epidemiol. 1996b; 143: 889–897. Hajjar RR, Kaiser FE, Morley JE. Outcomes of long-term testosterone replacement in older hypogonadal males: a retrospective analysis. J Clin Endocrinol Metab. 1997; 82: 3793–3796. Hanash KA, Mostofi KF. Androgen effect on prostate specific antigen secretion. J Surg Oncol. 1992; 49: 202–204. Harmon M. Longitudinal changes in serum testosterone concentrations in men. J Clin Endocrinol Metab. In press. Harman SM, Tsitouras PD. Reproductive hormones in aging men I. Measurement of sex steroids, basal luteinizing hormone and Leydig cell response to human chorionic gonadotropin. J Clin Endocrinol Metab. 1980; 51: 35–41. Harman SM, Tsitouras PD, Costa PT, Blackman MR. Reproductive hormones in aging men. II. Basal pituitary gonadotropins and gonadotropin responses to luteinizing hormone-releasing hormone. J Clin Endocrinol Metab. 1982; 54: 547–551. Harris T. Muscle mass and strength: relation to function in population studies. J Nutr. 1997; 27: 1004S–1006S. Herbst KL AB, Cherrier M., Craft S., Matsumoto AM, Bremner WJ. Testosterone administration improves spatial and verbal memory in normal men. J Invest Med. 1999; 47: 23A. Hobbs CJ, Jones RE, Plymate SR. Nandrolone, a 19-nortestosterone, enhances insulin-independent glucose uptake in normal men [see comments]. J Clin Endocrinol Metab. 1996; 81: 1582–1585. Hoffman MA, DeWolf WC, Morgentaler A. Is low serum free testosterone a marker for high grade prostate cancer? J Urol. 2000; 163: 824–827. Holloszy JO. Workshop on sarcopenia: muscle atrophy in old age. J Gerontol. 1995; 50A (special): 1–161. Holmang A., Bjorntorp P. The effects of testosterone on insulin sensitivity in male rats. Acta Physiol Scand. 1992; 146: 505–510. Hurley BF, Seals DR, Hagberg JM, Goldberg AC, Ostrove SM, Holloszy JO, Wiest WG, Goldberg AP. High-density-lipoprotein cholesterol in bodybuilders v powerlifters. Negative effects of androgen use. JAMA. 1984; 252: 507–513. Jaffe MD. Effect of testosterone cypionate on postexercise ST segment depression. Br Heart J. 1977; 39: 1217–1222. Jain P., Rademaker AW, McVary KT. Testosterone supplementation for erectile dysfunction: results of a meta-analysis. J Urol. 2000; 164: 371–375. Janowsky JS, Oviatt SK, Orwoll ES. Testosterone influences spatial cognition in older men. Behav Neurosci. 1994; 108: 325–332. Kaiser FE, Viosca SP, Morley JE, Mooradian AD, Davis SS, Korenman SG. Impotence and aging: clinical and hormonal factors. J Am Geriatr Soc. 1988; 36: 511–519. Katznelson L., Finkelstein JS, Schonenfeld DA, Rosenthal DI, Anderson EJ, Klibanski A. Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism. J Clin Endocrinol Metab. 1996; 81: 4358–4365. Kendall DA, Stancel GM, Enna SJ. The influence of sex hormones on antidepressant-induced alterations in neurotransmitter receptor binding. J Neurosci. 1982; 2: 354–360. Kenny AM, Gallagher JC, Prestwood KM, Gruman CA, Raisz LG. Bone density, bone turnover, and hormone levels in men over age 75. J Gerontol A Biol Sci Med Sci. 1998; 53: M419–M425. Khaw KT, Barrett-Connor E. Lower endogenous androgens predict central adiposity in men. Ann Epidemiol. 1992; 2: 675–682. Khosla S., Melton LJ III, Atkinson EJ, O'Fallon WM, Klee GG, Riggs BL. Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: a key role for bioavailable estrogen. J Clin Endocrinol Metab. 1998; 83: 2266–2274. Kohrt WM, Malley MT, Dalsky GP, Holloszy JO. Body composition of healthy sedentary and trained, young and older men and women. Med Sci Sports Exerc. 1992; 24: 832–837. Korenman SG, Morley JE, Mooradian AD, Davis SS, Kaiser FE, Silver AJ, Viosca SP, Garza D. Secondary hypogonadism in older men: its relation to impotence. J Clin Endocrinol Metab. 1990; 71: 963–969. Kouri EM, Lukas SE, Pope HG Jr, Oliva PS. Increased aggressive responding in male volunteers following the administration of gradually increasing doses of testosterone cypionate. Drug Alcohol Depend. 1995; 40: 73–79. Kwan M., Greenleaf WJ, Mann J., Crapo L., Davidson JM. The nature of androgen action on male sexuality: a combined laboratory-self-report study on hypogonadal men. J Clin Endocrinol Metab. 1983a; 57: 557–562. Kwan M., Greenleaf WJ, Mann J., Crapo L., Davidson JM. The nature of androgen action on male sexuality: a combined laboratory self-report study on hypogonadal men. J Clin Endocrinol Metab. 1983b; 57: 557–562. Leifke E., Korner HC, Link TM, Behre HM, Peters PE, Nieschlag E. Effects of testosterone replacement therapy on cortical and trabecular bone mineral density, vertebral body area and paraspinal muscle area in hypogonadal men. Eur J Endocrinol. 1998; 138: 51–58. Lexell J. Human aging, muscle mass, and fiber type composition. J Gerontol. 1995; 50A: 11–16. Lexell J., Henriksson-Larsen K., Wimblod B., Sjostrom M. Distribution of different fiber types in human skeletal muscles: effects of aging studied in whole muscle cross section. Muscle Nerve. 1983; 6: 588–595. Litwin MS, Nied RJ, Dhandani N. Health-related quality of life in men with erectile dysfunction. J Gen Intern Med. 1998; 13: 159–166. Lord SR, Rogers MW, Howland A., Fitzpatrick R. Lateral stability, sensorimotor function and falls in older people. J Am Geriatr Soc. 1999; 47: 1077–1081. Lustig RH. Sex hormone modulation of neural development in vitro. Horm Behav. 1994; 28: 383–395. Lu S., Simon NG, Wang Y., Hu S. Neural androgen receptor regulation: effects of androgen and antiandrogen. J Neurobiol. 1999; 41: 505–511. Lugg J., Ng C., Rajfer J., Gonzalez-Cadavid N. Cavernosal nerve stimulation in the rat reverses castration-induced decrease in penile NOS activity. Am J Physiol. 1996; 271: E354–E361. Maccoby EE JC. The Psychology of Sex Differences. Stanford, Calif: Stanford University Press; 1974. Mårin P., Odén B., Björntorp P. Assimilation and mobilization of triglycerides in subcutaneous abdominal and femoral adipose tissue in vivo in men: effects of androgens. J Clin Endocrinol Metab. 1995; 80: 239–243. Margolese HC. The male menopause and mood: testosterone decline and depression in the aging male—is there a link? J Geriatr Psychiatry Neurol. 2000; 13: 93–101. Marin P., Holmang S., Jonsson L., Sjostrom L., Kvist H., Holm G., Lindstedt G., Bjorntorp P. The effects of testosterone treatment on body composition and metabolism in middle-aged obese men. Int J Obes. 1992a; 16: 991–997. Marin P., Krotkiewski M., Bjorntorp P. Androgen treatment of middle-aged, obese men: effects on metabolism, muscle and adipose tissues. Eur J Med. 1992b; 1: 329–336. Matsumoto AM, Sandblom RE, Schoene RB, Lee KA, Giblin EC, Pierson DJ, Bremner WJ. Testosterone replacement in hypogonadal men: effects on obstructive sleep apnoea, respiratory drives, and sleep. Clin Endocrinol (Oxf). 1985; 22: 713–721. Mauras N., Hayes V., Welch S., Rini A., Helgeson K., Dokler M., Veldhuis JD, Urban RJ. Testosterone deficiency in young men: marked alterations in whole body protein kinetics, strength, and adiposity. J Clin Endocrinol Metab. 1998; 83: 1886–1892. Meikle AW, Arver S., Dobs AS, Adolfsson J., Sanders SW, Middleton RG, Stephenson RA, Hoover DR, et al. Prostate size in hypogonadal men treated with a nonscrotal permeation-enhanced testosterone transdermal system. Urology. 1997; 49: 191–196. Melton LJ 3rd, Khosla S., Riggs BL. Epidemiology of sarcopenia. Mayo Clin Proc. 2000; 75 (Suppl): S10–S13. Michikawa Y., Mazzucchelli F., Bresolin N., Scarlato G., Attardi G. Aging-dependent large accumulation of point mutations in the human mtDNA control region for replication. Science. 1999; 286: 774–779. Morgentaler A., Bruning CO 3rd, DeWolf WC. Occult prostate cancer in men with low serum testosterone levels. JAMA. 1996; 276: 1904–1906. Morley JE, Charlton E., Patrick P., Kaiser FE, Cadeau P., McCready D., Perry HM. Validation of a screening questionnaire for androgen deficiency in aging males. Metabolism. 2000; 49: 1239–1242. Morley JE, Kaiser FE, Perry HM 3rd, Patrick P., Morley PM, Stauber PM, Vellas B., Baumgartner RN, Garry PJ. Longitudinal changes in testosterone, luteinizing hormone, and follicle-stimulating hormone in healthy older men. Metabolism. 1997; 46: 410–413. Morley JE, Korenman SG, Mooradian AD, Kaiser FE. Sexual dysfunction in the elderly male [clinical conference]. J Am Geriatr Soc. 1987; 35: 1014–1022. Morley JE, Perry HM III, Kaiser FE, Kraenzle D., Jensen J., Houston K., Mattammal M., Perry HM. Effects of testosterone replacement therapy in old hypogonadal males: a preliminary study. J Am Geriatr Soc. 1993; 41: 149–152. Mulligan T., Iranmanesh A., Johnson ML, Straume M., Veldhuis JD. Aging alters feed-forward and feedback linkages between LH and testosterone in healthy men. Am J Physiol. 1997; 273 (4 part 2): R1407–R1413. Murono EP, Nankin HR, Lin T., Osterman J. The aging Leydig cell: VI. Response of testosterone precursors to gonadotropin in men. Acta Endocrinol (Copenhagen). 1982; 100: 455–461. Naets JP, Wittek M. The mechanism of action of androgens on erythropoiesis. Ann NY Acad Sci. 1968; 149: 366–376. Nankin HR, Calkins JH. Decreased bioavailable testosterone in aging normal and impotent men. J Clin EndocrinolMetab. 1986; 63: 1418–1420. Nathan L., Shi W., Dinh H., Lusis AJ, Chaudhuri G. Testosterone inhibits early atherogenesis by conversion to estradiol: critical role of aromatase. Proc Natl Acad Sci USA. 2001; 98: 3589–3593. Nieschlag E., Lammer U., Freischem CW, Langer K., Wickings EJ. Reproductive function in young fathers and grandfathers. J Clin Endocrinol Metab. 1982; 51: 675–681. Novak LP. Aging, total body potassium, fat free-mass, and cell mass in males and females between ages 18–85 years. J Gerontol. 1972; 27: 438–443. Ong PJ, Patrizi G., Chong WC, Webb CM, Hayward CS, Collins P. Testosterone enhances flow-mediated brachial artery reactivity in men with coronary artery disease. Am J Cardiol. 2000; 85: 269–272. Phillips GB, Pinkernell BH, Jing TY. The association of hypotestosteronemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol. 1994; 14: 701–706. Pirke KM, Doerr P. Age related changes and interrelationships between plasma testosterone, oestradiol and testosterone-binding globulin in normal adult males. Acta Endocrinol (Copenhagen). 1973; 74: 792–800. Pope HG Jr, Katz DL. Affective and psychotic symptoms associated with anabolic steroid use. Am J Psychiatry. 1988; 145: 487–490. Proctor DN, Balagopal P., Nair KS. Age-related sarcopenia in humans is associated with reduced synthetic rates of specific muscle proteins. J Nutr. 1998; 128: 351S–355S. Rabkin JG, Ferrando SJ, Wagner GJ, Rabkin R. DHEA treatment for HIV+ patients: effects on mood, androgenic and anabolic parameters. Psychoneuroendocrinology. 2000a; 25: 53–68. Rabkin JG, Wagner GJ, Rabkin R. A double-blind, placebo-controlled trial of testosterone therapy for HIV-positive men with hypogonadal symptoms. Arch Gen Psychiatry. 2000b; 57: 141–147; discussion 155–156. Ramirez ME, McMurry MP, Wiebke GA. Evidence for sex steroid inhibition of lipoprotein lipase in men: comparison of abdominal and femoral adipose
Referência(s)